What oral terbinafine dosage and duration should be used to treat tinea corporis in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Terbinafine for Tinea Corporis

For adult tinea corporis, use oral terbinafine 250 mg once daily for 1-2 weeks, though emerging resistance patterns and poor cure rates in recent studies suggest this may be inadequate for many cases. 1

FDA-Approved Dosing

The FDA label for terbinafine does not specifically list tinea corporis as an approved indication—it is only approved for onychomycosis 1. However, terbinafine has extensive off-label use and research support for superficial dermatophyte infections.

Evidence-Based Dosing Recommendations

Standard Regimen

  • Dose: 250 mg once daily
  • Duration: 1-2 weeks for tinea corporis 2
  • This represents the traditional approach supported by older literature

Ultra-Short Course Options

Historical studies demonstrated efficacy with remarkably brief courses:

  • 1 week therapy: 250 mg daily for 7 days showed complete mycological clearance in all patients at 6-week follow-up 3
  • 2-3 day therapy: Even 250 mg daily for just 2-3 consecutive days showed 47-67% mycological cure rates 4

Critical Caveats and Emerging Concerns

Poor Contemporary Efficacy

A 2023 randomized trial revealed alarming treatment failure rates 5:

  • Only 25.9% mycological cure at 4 weeks with 250 mg daily
  • Only 20% overall cure rate at study end
  • Doubling the dose to 500 mg daily provided no additional benefit (33.3% cure rate, P=0.82)
  • This suggests either resistant organisms or inadequate treatment duration

Terbinafine Resistance

Emerging resistance is a serious concern, particularly with certain strains:

  • Trichophyton mentagrophytes genotype VIII (Indian genotype) shows point mutations in the SQLE gene conferring terbinafine resistance 6
  • Trichophyton rubrum strains with I479T and I479V mutations demonstrate clinical resistance despite initial in vitro sensitivity 7
  • These resistant strains are spreading globally due to international travel 6

Practical Algorithm

For treatment-naive tinea corporis in adults:

  1. First-line: Terbinafine 250 mg daily for 4 weeks (not 1-2 weeks given poor contemporary cure rates) 5

    • Consider adding topical antifungal (clotrimazole, miconazole) for synergy
  2. If no improvement after 2 weeks or recurrence:

    • Suspect resistance
    • Switch to itraconazole 100-200 mg daily for 2 weeks 2, 8
    • Consider mycological culture with susceptibility testing
  3. For extensive disease (>5% BSA):

    • Consider starting with itraconazole 200-400 mg daily given better cure rates in recent trials 8

Monitoring and Safety

Baseline liver function tests are mandatory before initiating terbinafine due to risk of hepatotoxicity 1. Additional warnings include:

  • Taste and smell disturbances (may be permanent)
  • Severe neutropenia
  • Stevens-Johnson syndrome/TEN
  • Depressive symptoms 1

Relapse Rates

Expect high relapse rates (~47%) regardless of initial dose used 8. This necessitates:

  • Follow-up at 4-8 weeks post-treatment
  • Patient education about recurrence risk
  • Consideration of longer treatment courses than historically recommended

The evidence suggests that traditional 1-2 week courses are insufficient in the current era of resistant dermatophytes, and 4-week courses with consideration of alternative agents like itraconazole should be the contemporary standard.

Related Questions

What are the appropriate dosing, duration, and safety considerations for oral and topical terbinafine in treating dermatophyte skin infections and onychomycosis?
What is the appropriate duration of oral terbinafine therapy for tinea cruris in a healthy adult?
What is the recommended duration of treatment with terbinafine for tinea corporis?
In an adult with normal liver function and recurrent tinea corporis, is a weekly dosing schedule of terbinafine appropriate?
What is the recommended terbinafine dosage for treating tinea corporis in adults and children?
How should I evaluate and manage a patient with a persistent dry cough and abdominal distension since being intubated for a procedure on [DATE]?
Should a 71-year-old woman with total cholesterol 244 mg/dL, triglycerides 68 mg/dL, high-density lipoprotein (HDL) 96 mg/dL, calculated low-density lipoprotein (LDL) 134 mg/dL, non‑high-density lipoprotein (non‑HDL) 148 mg/dL, and no prior history of heart disease or stroke be started on a statin?
Which measurement obtained from a right‑heart catheterization indicates diastolic dysfunction?
In an asymptomatic patient with an incidentally discovered small pericardial effusion and normal thyroid function tests and inflammatory markers, how extensive should the diagnostic workup be?
What is levodropropizine, including its indications, dosage for various age groups, contraindications, side effects, and alternative antitussive options?
In a patient with compensated metabolic acidosis, arterial pCO2 of 19 mm Hg and bicarbonate of 12.7 mmol/L, should sodium bicarbonate be administered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.